NCT06838169Active, not recruiting
The Effect of Vırtual Realıty Glasses on Heart Faılure Patıents
Effects of Breathıng Exercıses wıth Vırtual Realıty Glasses on Anxıety Levels, Sleep Qualıty and Respıratory Parameters in Heart Faılure Patıents
Source: ClinicalTrials.gov · Last updated 30 Sept 2026
Brief summary (registry, in English)
Anxiety and sleep disorders are among the most common symptoms in heart failure patients. In addition to pharmacological methods for anxiety and sleep disorders, non-pharmacological methods can also be used. Among these, anxiety and sleep disorders can be prevented with virtual reality glasses aimed at distraction. This study will be conducted to evaluate the effect of breathing exercises performed with virtual reality glasses on anxiety, sleep quality, and respiratory parameters. The study will be conducted with a total of 45 patients, 15 virtual reality glasses + breathing exercises, 15 breathing exercises, and 15 controls. Those in the virtual reality glasses + breathing exercises group will perform breathing exercises with virtual reality glasses once a day for 7 days. Those in the breathing exercises group will perform only breathing exercises once a day for 7 days. Anxiety, sleep disorders, and respiratory parameters of the patients will be examined.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- First submitted
- 16 Jan 2025
- Start date
- 1 Oct 2025
- Primary completion date
- 1 Dec 2025
- Lead sponsor
- Bayburt University
- Diseases
- Heart failure
- NCT number
- NCT06838169
What you commit to
- Study type: Interventional
- Planned participants: 45
- From 1 Oct 2025 to the primary completion date, 1 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Life signs are so abnormal as to preclude intervention,
- Patients with migraine, vertigo, active nausea-vomiting, headache, dizziness will not be included in the study.
Who the study is looking for
- 18 years of age or older,
- Verbal communication,
- Place and time oriented,
- Without any psychiatric illness,
- Patients diagnosed with HF with NYHA class III-IV symptoms,
- Left ventricular ejection fraction ≥50% (LVEF-CF/HFpEF), between 40-49% (SEF-CF/HFmrEF), HF below 40% (DEF-CF/HFrEF),
- High levels of natriuretic peptides (BNP\>35 pg/mL and/or NTproBNP\>125 pg/mL),
- There is no deformity or diagnosis related to the musculoskeletal system that may prevent breathing exercise,
- Chronic diseases such as hypertension (Stage 1 and 2 HT) and diabetes mellitus are stable and the treatment for these diagnoses has not been changed in the last month,
- Who have not previously received respiratory exercise training and have not participated in a rehabilitation program,
- Patients who volunteer to participate in the study will be included in the study
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| T.C. Erciyes University Faculty of Medicine Hospitals Coordinator of this site? Confirm its status | Kayseri | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.